Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population

References

• Alfirevic Z, Simundic AM, Nikolac N, Sobocan N, Alfirevic I, Stefanovic M, Vucicevic Z, Topic E. 2010. Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-15G/4G polymorphism in patients with venous thromboembolism: Croatian case-control study. Bioch Med 20:229–235
   Web of Science ®Google Scholar
• Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J. 1999. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost 81:506–510
   PubMed Web of Science ®Google Scholar
• Angchaisuksiri P. 2011. Venous thromboembolism in Asia–an unrecognised and under-treated problem? Thromb Haemost 106:585–590
   PubMed Web of Science ®Google Scholar
• Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen MB. 1999. Prevalence of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 61:265–267
   PubMed Web of Science ®Google Scholar
• Avdonin PV, Kirienko AI, Kozhevnikova LM, Shostak NA, Babadaeva NM, Leont’ev SG, Petukhov EB, et al. 2006. C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism. [Article in Russian] Ter Arkh 78:70–76
   PubMed Web of Science ®Google Scholar
• Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM. 2007. The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation. Stroke 38:106–171
   Google Scholar
• Cabeda JM, Pereira M, Oliveira JM, Estevinho A, Pereira I, Morais S, Justica B, Campos M. 2002. Advances in the genotyping of thrombosis genetic risk factors: clinical and laboratory implications. Pathophysiol Haemost Thromb 32:235–240
   PubMed Web of Science ®Google Scholar
• Camilleri RS, Peebles D, Portmann C, Everington T, Cohen H. 2004. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Blood Coagul Fibrinolysis 15:139–147
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L. 1999. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasmaprothrombin levels. Thromb Res 93:1–8
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113
   PubMed Web of Science ®Google Scholar
• Gandrille S, Alhenc-Gelas M, Aiach M. 1995. A rapid screening method for the Factor V Arg506 > Gln variant. Blood Coagul Fibrynolysis 6:245–247
   PubMed Web of Science ®Google Scholar
• Gialeraki A, Politou M, Rallidis L, Merkouri E, Markatos C, Kremastinos D, Travlou A. 2008. Prevalence of prothrombotic polymorphisms in Greece. Genet Test 12:541–547
   PubMedGoogle Scholar
• Hussein AS. 2012. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T. J Thromb Thrombolysis 34:383–387
   PubMed Web of Science ®Google Scholar
• Karic A, Trezic R, Jerkic Z, Mustedanagic-Mujanovic J. 2013. The Frequency of C677T Methylenetetrahydrofolate Reductase (MTHFR) polymorphism in Southern East Bosnian population. J Biomet Biostat 4:4
   Google Scholar
• Keijzer MBAJ, den Heijer M, Blom HJ, Bos GMJ, Willems HPJ, Gerrits WBJ, Rosendaal FR. 2002. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 88:72–78
   Google Scholar
• Kiseljakovic E, Resic H, Kapur L, Hasic S, Jadric R. 2010. Methylenetetrahydrofolate Reductase gene polymorphism in patients receiving hemodialysis. Bosn J Basic Med Sci 10:S91–95
   PubMed Web of Science ®Google Scholar
• Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, et al. 2001. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 7:346–350
   PubMed Web of Science ®Google Scholar
• Machac S, Lubusky M, Prochazka M, Streda R. 2006. Prevalence of inherited thrombophilia in patients with severe ovarian hyperstimulation syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150:289–292
   PubMedGoogle Scholar
• Meglic L, Stegnar M, Milanez T, Bozic M, Peterlin B, Peternel P, Novak-Antolic Z. 2003. Factor V Leiden, prothrombin 20210G –>A, methylenetetrahydrofolate reductase 677C –> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism. Eur J Obstet Gynecol Reprod Biol 111:157–163
   PubMed Web of Science ®Google Scholar
• Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA. 2002. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. ThrombHaemost 87:779–785
   Google Scholar
• Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M. 2005. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg 41:808–815
   PubMed Web of Science ®Google Scholar
• Pauer HU, Voigt-Tschirschwitz T, Hinney B, Burfeind P, Wolf C, Emons G, Neesen J. 2003. Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obstet Gynecol Scand 82:942–947
   PubMed Web of Science ®Google Scholar
• Penco S, Grossi E, Cheng S, Intraligi M, Maurelli G, Patrosso MC, Marocchi A, Buscema M. 2005. Assessment of the role of genetic polymorphism in venous thrombosis through artificial neural networks. Ann Hum Genet 69:693–706
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. 1996. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703
   Google Scholar
• Prochazka M, Lubusky M, Slavík L, Hrachovec P, Zielina P, Kudela M, Lindqvist PG. 2007. Frequency of selected thrombophilias in women with placental abruption. Aust N Z J Obstet Gynaecol 47:297–301
   PubMed Web of Science ®Google Scholar
• Raposo M, Sousa P, Nemeth S, Couto A, Santos M, Pinheiro J, Peixoto M, et al. 2011. Polymorphism in cardiovascular diseases (CVD) susceptibility loci in the azores islands (Portugal). OJGEN 1:48–53
   Google Scholar
• Tatarsky P, Kucherenko A, Livshits L. 2010. Allelic polymorphism of F2, F5 and MTHFR genes in population of Ukraine. Tsitol Genet 44:3–8
   Google Scholar
• Tomaiuolo R, Bellia C, Caruso A, Di Fiore R, Quaranta S, Nota D, Noto D, et al. 2012. Prothrombotic gene variants as risk factors of acute myocardial infarction in young women. J Transl Med 10:235
   PubMedGoogle Scholar
• Valjevac A, Mehic B, Kiseljakovic E, Ibrulj S, Garstka A, Adler G. 2013. Prevalence of 1691G > A FV mutation in females from Bosnia and Herzegovina – a preliminary report. Bosn J Basic Med Sci 13:31–33
   PubMed Web of Science ®Google Scholar